Accuray (ARAY) Debt to Equity (2015 - 2026)
Accuray posted quarterly Debt to Equity of $3.48 for Q1 2026, down 0.68% year-on-year from $3.5 in Q1 2025, and up 36.84% on a QoQ basis from $2.54 in Q4 2025.
Accuray (ARAY) has 12 years of Debt to Equity data on file, last reported at $3.48 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity fell 0.68% year-over-year to $3.48; the trailing twelve-month figure through Mar 2026 stood at $3.48 (down 0.68% YoY), and the FY2025 full-year result was $1.68, down 55.95% from the prior year.
- Debt to Equity for Q1 2026 stood at $3.48, up from $2.54 in the prior quarter.
- Across five years, Debt to Equity topped out at $5.93 in Q1 2022 and bottomed at $1.68 in Q2 2025.
- The 5-year median for Debt to Equity is $3.5 (2025), against an average of $3.64.
- The widest annual swing landed in 2022, when Debt to Equity surged 34.39%; it then plunged 55.95% in 2025.
- A 5-year view of Debt to Equity shows it stood at $3.47 in 2022, then rose by 5.54% to $3.67 in 2023, then retreated by 0.07% to $3.66 in 2024, then plunged by 30.59% to $2.54 in 2025, then surged by 36.84% to $3.48 in 2026.
- The last three Debt to Equity figures came in at $3.48 (Q1 2026), $2.54 (Q4 2025), and $2.27 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn | 3.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.48 |
| Dec 31, 2025 | 2.54 |
| Sep 30, 2025 | 2.27 |
| Jun 30, 2025 | 1.68 |
| Mar 31, 2025 | 3.50 |
| Dec 31, 2024 | 3.66 |
| Sep 30, 2024 | 3.76 |
| Jun 30, 2024 | 3.82 |
| Mar 31, 2024 | 4.89 |
| Dec 31, 2023 | 3.67 |
| Sep 30, 2023 | 3.46 |
| Jun 30, 2023 | 3.30 |
| Mar 31, 2023 | 5.32 |
| Dec 31, 2022 | 3.47 |
| Sep 30, 2022 | 3.75 |
| Jun 30, 2022 | 3.39 |
| Mar 31, 2022 | 5.93 |
| Dec 31, 2021 | 3.57 |
| Sep 30, 2021 | 4.32 |
| Jun 30, 2021 | 2.52 |
| Mar 31, 2021 | 6.21 |
| Dec 31, 2020 | 2.32 |
| Sep 30, 2020 | 2.66 |
| Jun 30, 2020 | 2.97 |
| Mar 31, 2020 | 8.50 |
| Dec 31, 2019 | 3.28 |
| Sep 30, 2019 | 4.60 |
| Jun 30, 2019 | 3.21 |
| Mar 31, 2019 | 3.06 |
| Dec 31, 2018 | 2.97 |
| Sep 30, 2018 | 2.74 |
| Jun 30, 2018 | 2.70 |
| Mar 31, 2018 | 3.00 |
| Dec 31, 2017 | 3.46 |
| Sep 30, 2017 | 3.25 |
| Jun 30, 2017 | 3.54 |
| Mar 31, 2017 | 3.74 |
| Dec 31, 2016 | 3.65 |
| Sep 30, 2016 | 3.28 |
| Jun 30, 2016 | 3.53 |
| Mar 31, 2016 | 3.36 |
| Dec 31, 2015 | 3.40 |
| Sep 30, 2015 | 3.19 |
| Jun 30, 2015 | 2.63 |